
ALD-ALLY
Alcohol-associated Liver Disease patients deserve ALcohol LiteracY
DALLAS 2.0
FEATURING
April 1-2, 2027
In-Person and Virtual
Presented by Baylor Scott & White Health
April 1-2, 2027
Dallas, Texas
Location TBD
Join us Thursday and Friday for a special 3rd Annual ALD-ALLY Conference featuring Dallas 2.0!
We welcome you as we bring together renowned experts to delve into the latest developments in ALD and MetALD.
ALD-ALLY is a call to action for advancing the science and care of patients with alcohol-associated liver disease (ALD) by gathering international experts to lead a multidisciplinary dialogue among a wide spectrum of stakeholders. Our intent is for ALD-ALLY to become the premier annual ALD meeting focused on actionable initiatives and collaborations through state-of-the-art lectures, academic debates, and patient advocacy in a lively in-person, discussion-encouraged setting.
Be an ALLY and join us in Dallas!
*Dallas 2.0 : a structured consensus expert workshop to develop guidance for liver transplantation for alcohol-associated liver disease*

Gene Im, MD, FAASLD
Columbia University, NY
Course Co-Chair

Sumeet Asrani, MD, MSc
Baylor Scott & White, Dallas, TX
Course Co-Chair

Marina Serper, MD, MS
University of Pennsylvania
ALD-ALLY Course Directors

Juan Pablo Arab, MD, FRCPC
Virginia Commonwealth University

Jessica Mellinger, MD
Henry Ford Health, Detroit, MI

Gerald S. Winder, MD, MSc, FACLP
Henry Ford Health, Detroit, MI
Please see Agenda and Registration pages